Seattle biotech startup Deverra Therapeutics raising cash to develop cellular immunotherapies by Nate Bek on September 19, 2023September 19, 2023 at 9:27 pm Seattle biotech company Deverra Therapeutics is raising cash for its cellular immunotherapies platform that helps doctors treat patients with cancer and other infectious diseases. A new SEC filing reveals that… Read More